Validation of a screening score model to predict the development of retinopathy of prematurity

Johanes E Siswanto1,2, Asri C Adisasmita3, Sudarto Ronoatmodjo3

  • 1Neonatology Working Group, Department of Pediatrics, Harapan Kita National Women and Children Health Centre, Jakarta, Indonesia. edyjo15@yahoo.com.

Scientific Reports
|November 18, 2025
PubMed

Insights

Developing risk-based screening models for retinopathy of prematurity (ROP) in low-income countries is crucial. These validated models improve early detection of ROP, preventing blindness in premature infants.

Area of Science:

  • Neonatal ophthalmology
  • Public health
  • Medical screening

Background:

  • Retinopathy of prematurity (ROP) is a major cause of preventable blindness in preterm infants, particularly in low- and middle-income countries.
  • Existing screening criteria from high-income nations may not be suitable for resource-limited settings.

Purpose of the Study:

  • To develop and validate pragmatic, risk-based screening models for ROP using Indonesian neonatal data.
  • To provide a practical tool for optimizing ROP case finding in resource-limited environments.

Main Methods:

  • Development of two models (FiO₂-based and SpO₂-based) using multicenter Indonesian neonatal data.
  • Internal validation assessing discrimination, sensitivity, and specificity.
  • External validation in a separate cohort of preterm infants.

Main Results:

  • Significant predictors for ROP included intrauterine growth restriction, oxygen exposure, exchange transfusion, and socioeconomic status.
  • Internal validation showed moderate discrimination (AUC 0.719-0.732).
  • External validation of a combined rule demonstrated high sensitivity (84%) and specificity (81%), with strong predictive values.

Conclusions:

  • Locally validated, risk-based screening scores are a practical complement to existing ROP screening criteria.
  • These models can optimize ROP case finding in resource-limited settings, aiding in the prevention of blindness.